Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009695 |
---|---|
Receipt number | R000011366 |
Scientific Title | Multicenter Randomized Phase II Study of consecutive-day versus alternate-day treatment with S-1 as Second-line chemotherapy in advanced pancreatic cancer. |
Date of disclosure of the study information | 2013/01/04 |
Last modified on | 2017/10/31 21:27:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/01/04 21:26:20 | ||
2 | Update | 2014/01/22 21:17:53 | Email Institutions |
|
3 | Update | 2014/01/22 21:19:37 | Recruitment status |
|
4 | Update | 2015/01/05 20:07:50 | Last follow-up date |
|
5 | Update | 2015/07/10 21:27:35 | Results |
|
6 | Update | 2016/01/04 20:53:12 | Anticipated trial start date Last follow-up date Results |
|
7 | Update | 2017/01/07 19:02:09 | Name of primary person or sponsor Organization Category of Funding Organization |
|
8 | Update | 2017/01/07 19:04:12 | Recruitment status |
|
9 | Update | 2017/07/09 12:23:03 | Recruitment status |
|
10 | Update | 2017/10/31 21:27:36 | Recruitment status Last follow-up date Results |